Better adherence to guidelines for food allergen introduction to infants may improve incidence of EoE and food allergy.
A 2026 Young Physician-Scientist Award honors Uchida's work in immune-mediated gastrointestinal disease and her translation of discoveries into better patient care.
GAITHERSBURG, Md. and CAMBRIDGE, United Kingdom, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Revolo Biotherapeutics Limited (“Revolo”) today announced ...
Good afternoon, everyone, and welcome to our fourth quarter 2025 earnings call. Bob Bradway will lead the call today and be ...
As of Friday, January 30, Apogee Therapeutics, Inc.’s APGE share price has dipped by 7.75%, which has investors questioning ...
Amgen delivered a strong fourth quarter of 2025 and looks well-positioned to absorb the LOEs on Prolia, Xgeva, and Ravicti in ...
Data from the BREADTH Phase 2b asthma trial is expected to be reported in late-2027Data from the ongoing parallel BROADEN2 Phase 2b atopic ...
Data from the BREADTH Phase 2b asthma trial is expected to be reported in late-2027 Data from the ongoing parallel BROADEN2 Phase 2b atopic dermatitis trial is expected to be reported by mid-2027 WATE ...
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2025 Earnings Call Transcript January 28, 2026 Teva Pharmaceutical ...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q4 2025 Earnings Call Transcript January 30, 2026 Regeneron Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $11.44, expectations were ...
Amgen (NASDAQ:AMGN) executives highlighted broad-based growth in 2025 and laid out expectations for continued momentum in ...
Infectious mononucleosis, often called "mono," is a viral illness best known for causing extreme fatigue, sore throat and swollen glands.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results